Ahmed M. Elgehama

State Key Laboratory Of Pharmaceutical Biotechnology
Nanjing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Identification of a RIPK2-Regulated Gene Signature as a Candidate Biomarker for RIPK2 Activity and Prognosis in Prostate Cancer.

Identification of a RIPK2-Regulated Gene Signature as a Candidate Biomarker for RIPK2 Activity and Prognosis in Prostate Cancer.

Journal: bioRxiv : the preprint server for biology
Published: July 14, 2025

A RIPK2 activity signature in prostate cancer: Modulation by RIPK2 inhibition and clinical association.

A RIPK2 activity signature in prostate cancer: Modulation by RIPK2 inhibition and clinical association.

Journal: Translational oncology
Published: June 06, 2025

Targeting the PTP1B-Bcr-Abl1 interaction for the degradation of T315I mutant Bcr-Abl1 in chronic myeloid leukemia.

Targeting the PTP1B-Bcr-Abl1 interaction for the degradation of T315I mutant Bcr-Abl1 in chronic myeloid leukemia.

Journal: Cancer science
Published: July 01, 2022

Selective obstruction of the mTORC2 complex by a naturally occurring cholestane saponin (OSW-1) for inhibiting prostate cancer cell growth.

Selective obstruction of the mTORC2 complex by a naturally occurring cholestane saponin (OSW-1) for inhibiting prostate cancer cell growth.

Journal: Journal of Asian natural products research
Published: July 22, 2021

Selective targeting of the androgen receptor-DNA binding domain by the novel antiandrogen SBF-1 and inhibition of the growth of prostate cancer cells.

Selective targeting of the androgen receptor-DNA binding domain by the novel antiandrogen SBF-1 and inhibition of the growth of prostate cancer cells.

Journal: Investigational new drugs
Published: September 18, 2020

Inducible SHP-2 activation confers resistance to imatinib in drug-tolerant chronic myeloid leukemia cells.

Inducible SHP-2 activation confers resistance to imatinib in drug-tolerant chronic myeloid leukemia cells.

Journal: Toxicology and applied pharmacology
Published: July 12, 2018

Andrographolide sulfonate improves Alzheimer-associated phenotypes and mitochondrial dysfunction in APP/PS1 transgenic mice.

Andrographolide sulfonate improves Alzheimer-associated phenotypes and mitochondrial dysfunction in APP/PS1 transgenic mice.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 29, 2017

A natural compound jaceosidin ameliorates endoplasmic reticulum stress and insulin resistance via upregulation of SERCA2b.

A natural compound jaceosidin ameliorates endoplasmic reticulum stress and insulin resistance via upregulation of SERCA2b.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 05, 2017

Loss of periplakin expression is associated with the tumorigenesis of colorectal carcinoma.

Loss of periplakin expression is associated with the tumorigenesis of colorectal carcinoma.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 29, 2016

Blockade of the interaction between Bcr-Abl and PTB1B by small molecule SBF-1 to overcome imatinib-resistance of chronic myeloid leukemia cells.

Blockade of the interaction between Bcr-Abl and PTB1B by small molecule SBF-1 to overcome imatinib-resistance of chronic myeloid leukemia cells.

Journal: Cancer letters
Published: August 10, 2015

Fumigaclavine C ameliorates dextran sulfate sodium-induced murine experimental colitis via NLRP3 inflammasome inhibition.

Fumigaclavine C ameliorates dextran sulfate sodium-induced murine experimental colitis via NLRP3 inflammasome inhibition.

Journal: Journal of pharmacological sciences
Published: March 31, 2015
Showing 1-11 of 11

Last Updated: 09/26/2026